mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |
mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.004 |
mRNA |
BRD-K50799972 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.005 |
mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.006 |
mRNA |
AZD-7545 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.008 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.01 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.01 |